• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙特两家医院 COVID-19 患者的死亡率模式:人口统计学、病因和治疗。

Mortality patterns among COVID-19 patients in two Saudi hospitals: Demographics, etiology, and treatment.

机构信息

Field Epidemiology Training Program Ministry of Health Riyadh Saudi Arabia.

Public Health Ministry of Health Riyadh Saudi Arabia.

出版信息

Influenza Other Respir Viruses. 2023 Mar 21;17(3):e13127. doi: 10.1111/irv.13127. eCollection 2023 Mar.

DOI:10.1111/irv.13127
PMID:36970568
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10030359/
Abstract

BACKGROUND

Saudi Arabia (SA) reported its first case of COVID-19 on 2 March 2020. Mortality varied nationwide; by April 14, 2020, Medina had 16% of SA's total COVID-19 cases and 40% of all COVID-19 deaths. A team of epidemiologists investigated to identify factors impacting survival.

METHODS

We reviewed medical records from two hospitals: Hospital A in Medina and Hospital B in Dammam. All patients with a registered COVID-related death between March and May 1, 2020, were included. We collected data on demographics, chronic health conditions, clinical presentation, and treatment. We analyzed data using SPSS.

RESULTS

We identified 76 cases: 38 cases from each hospital. More fatalities were among non-Saudis at Hospital A (89%) versus Hospital B (82%,  < 0.001). Hypertension prevalence was higher among cases at Hospital B (42%) versus Hospital A (21%) ( < 0.05). We found statistically significant differences ( < 0.05) in symptoms at initial presentation among cases at Hospital B versus Hospital A, including body temperature (38°C vs. 37°C), heart rate (104 bpm vs. 89 bpm), and regular breathing rhythms (61% vs. 55%). Fewer cases (50%) at Hospital A received heparin versus Hospital B (97%, -value < 0.001).

CONCLUSION

Patients who died typically presented with more severe illnesses and were more likely to have underlying health conditions. Migrant workers may be at increased risk due to poorer baseline health and reluctance to seek care. This highlights the importance of cross-cultural outreach to prevent deaths. Health education efforts should be multilingual and accommodate all literacy levels.

摘要

背景

沙特阿拉伯(SA)于 2020 年 3 月 2 日报告了首例 COVID-19 病例。全国的死亡率各不相同;到 2020 年 4 月 14 日,麦地那占沙特 COVID-19 总病例数的 16%,占所有 COVID-19 死亡人数的 40%。一组流行病学家进行了调查,以确定影响生存的因素。

方法

我们查阅了两家医院的病历:麦地那的医院 A 和达曼的医院 B。所有在 2020 年 3 月至 5 月 1 日期间与 COVID 相关的死亡病例均纳入研究。我们收集了人口统计学、慢性健康状况、临床表现和治疗的数据。我们使用 SPSS 分析数据。

结果

我们共发现了 76 例病例:每家医院 38 例。在医院 A(89%)而非医院 B(82%,<0.001)死亡的患者中非沙特人更多。高血压在医院 B(42%)的病例中比医院 A(21%)更为常见(<0.05)。我们发现,在医院 B 就诊的病例与医院 A 相比,初始症状存在统计学上的显著差异,包括体温(38°C 对 37°C)、心率(104 bpm 对 89 bpm)和正常的呼吸节律(61%对 55%)。在医院 A,接受肝素治疗的病例(50%)比医院 B(97%,-值<0.001)少。

结论

死亡的患者通常表现出更严重的疾病,并且更有可能存在潜在的健康状况。移民工人可能由于较差的基础健康状况和不愿寻求医疗服务而面临更高的风险。这突显了开展跨文化宣传以防止死亡的重要性。健康教育工作应该是多语言的,并适应所有的读写水平。

相似文献

1
Mortality patterns among COVID-19 patients in two Saudi hospitals: Demographics, etiology, and treatment.沙特两家医院 COVID-19 患者的死亡率模式:人口统计学、病因和治疗。
Influenza Other Respir Viruses. 2023 Mar 21;17(3):e13127. doi: 10.1111/irv.13127. eCollection 2023 Mar.
2
Risk factors associated with in-hospital mortality patients with COVID-19 in Saudi Arabia.与 COVID-19 住院患者死亡相关的风险因素在沙特阿拉伯。
PLoS One. 2022 Jun 24;17(6):e0270062. doi: 10.1371/journal.pone.0270062. eCollection 2022.
3
Survival, mortality, and related comorbidities among COVID-19 patients in Saudi Arabia: A hospital-based retrospective cohort study.在沙特阿拉伯,COVID-19 患者的生存、死亡率和相关合并症:一项基于医院的回顾性队列研究。
Saudi Med J. 2022 Aug;43(8):915-926. doi: 10.15537/smj.2022.43.8.20220182.
4
Epidemiological and clinical features of COVID-19 patients in Saudi Arabia.沙特阿拉伯 COVID-19 患者的流行病学和临床特征。
J Infect Public Health. 2021 Apr;14(4):437-443. doi: 10.1016/j.jiph.2021.01.003. Epub 2021 Jan 16.
5
Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study.沙特阿拉伯住院患者中的糖尿病和新冠病毒-19:一项单中心回顾性研究。
Cardiovasc Diabetol. 2020 Dec 5;19(1):205. doi: 10.1186/s12933-020-01184-4.
6
Clinical characteristics and outcome of Covid-19 illness and predictors of in-hospital mortality in Saudi Arabia.沙特阿拉伯的新冠病毒疾病的临床特征和转归以及住院死亡率的预测因素。
BMC Infect Dis. 2022 Dec 17;22(1):950. doi: 10.1186/s12879-022-07945-8.
7
A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.一项评估法匹拉韦和羟氯喹联合治疗中重度 COVID-19 住院成人的疗效和安全性的随机对照研究:研究方案的结构化总结。
Trials. 2020 Oct 31;21(1):904. doi: 10.1186/s13063-020-04825-x.
8
Cardiovascular Risk Factors Among Patients Infected with COVID-19 in Saudi Arabia.沙特阿拉伯 COVID-19 感染者的心血管危险因素。
Vasc Health Risk Manag. 2021 Apr 21;17:161-168. doi: 10.2147/VHRM.S300635. eCollection 2021.
9
Overview of clinical outcome and therapeutic effectiveness of Favipiravir in patients with COVID-19 admitted to intensive care unit, Riyadh, Saudi Arabia.沙特阿拉伯利雅得重症监护病房 COVID-19 患者使用法维拉韦的临床转归和治疗效果概述。
J Infect Public Health. 2022 Apr;15(4):389-394. doi: 10.1016/j.jiph.2022.01.013. Epub 2022 Feb 15.
10
Comparing pregnancy outcomes between symptomatic and asymptomatic COVID-19 positive unvaccinated women: Multicenter study in Saudi Arabia.比较有症状和无症状的 COVID-19 阳性未接种疫苗的女性的妊娠结局:沙特阿拉伯的多中心研究。
J Infect Public Health. 2022 Aug;15(8):845-852. doi: 10.1016/j.jiph.2022.06.002. Epub 2022 Jun 24.

引用本文的文献

1
Effect of the COVID-19 Pandemic on the Performance of Undergraduate Healthcare Students During Their Internship in Saudi Arabia.新冠疫情对沙特阿拉伯本科医学生实习表现的影响。
Adv Med Educ Pract. 2024 Jul 16;15:695-706. doi: 10.2147/AMEP.S464750. eCollection 2024.
2
Repurposing surgical wards in pandemics - An appraisal of outcomes of COVID-19 patients treated in Orthopaedic wards.大流行期间外科病房的重新利用——对在骨科病房接受治疗的COVID-19患者的治疗结果评估
J Family Med Prim Care. 2024 May;13(5):1868-1874. doi: 10.4103/jfmpc.jfmpc_1210_23. Epub 2024 May 24.

本文引用的文献

1
Elevated D-Dimer Levels Are Associated With Increased Risk of Mortality in Coronavirus Disease 2019: A Systematic Review and Meta-Analysis.D-二聚体水平升高与 2019 年冠状病毒病患者死亡率增加相关:系统评价和荟萃分析。
Cardiol Rev. 2020 Nov/Dec;28(6):295-302. doi: 10.1097/CRD.0000000000000330. Epub 2020 Jul 2.
2
Sex differential in COVID-19 mortality varies markedly by age.新冠病毒疾病(COVID-19)死亡率的性别差异在不同年龄段中有显著变化。
Lancet. 2020 Aug 22;396(10250):532-533. doi: 10.1016/S0140-6736(20)31748-7. Epub 2020 Aug 13.
3
Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis.与 COVID-19 死亡相关的临床特征、实验室结局特征、合并症和并发症:系统评价和荟萃分析。
Aging Clin Exp Res. 2020 Sep;32(9):1869-1878. doi: 10.1007/s40520-020-01664-3. Epub 2020 Jul 30.
4
D-dimer as an indicator of prognosis in SARS-CoV-2 infection: a systematic review.D-二聚体作为新型冠状病毒2型感染预后的指标:一项系统评价
ERJ Open Res. 2020 Jul 13;6(2). doi: 10.1183/23120541.00260-2020. eCollection 2020 Apr.
5
Blood type and outcomes in patients with COVID-19.COVID-19 患者的血型与结局。
Ann Hematol. 2020 Sep;99(9):2113-2118. doi: 10.1007/s00277-020-04169-1. Epub 2020 Jul 12.
6
Extrapulmonary manifestations of COVID-19.COVID-19 的肺外表现。
Nat Med. 2020 Jul;26(7):1017-1032. doi: 10.1038/s41591-020-0968-3. Epub 2020 Jul 10.
7
C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis.C 反应蛋白、降钙素原、D-二聚体和铁蛋白在严重 2019 冠状病毒病中的meta 分析。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620937175. doi: 10.1177/1753466620937175.
8
Clinical Features and Outcome of SARS-CoV-2 Infection in Children: A Systematic Review and Meta-analysis.儿童严重急性呼吸综合征冠状病毒 2 感染的临床特征和结局:系统评价和荟萃分析。
Indian Pediatr. 2020 Sep 15;57(9):820-826. doi: 10.1007/s13312-020-1961-0. Epub 2020 Jun 24.
9
Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19.ABO 血型分布与 COVID-19 患者临床特征的关系。
Clin Chim Acta. 2020 Oct;509:220-223. doi: 10.1016/j.cca.2020.06.026. Epub 2020 Jun 17.
10
Coronavirus disease 2019 (COVID-19) in children and/or adolescents: a meta-analysis.儿童和/或青少年 2019 冠状病毒病(COVID-19):一项荟萃分析。
Pediatr Res. 2021 Mar;89(4):733-737. doi: 10.1038/s41390-020-1015-2. Epub 2020 Jun 17.